使用改性乙醇注射方法制备的mRNA脂质组作为瘤疫苗的评估
Yoshiyuki Hattori1, Min Tang1, Junnosuke Sato2
1Department of Molecular Pharmaceutics, Hoshi University, Tokyo, Japan.
Journal of drug targeting
|July 22, 2024
概括
用PEGylation优化的信使RNA (mRNA) 脂质复合减少了肺部积累,并有效抑制了瘤生长. 这些新型的脂质复合体显示出作为强有力的抗瘤免疫反应的mRNA疫苗的前景.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 使者RNA (mRNA) 脂质复合物对蛋白质表达和免疫有效.
- 之前的配方显示高蛋白表达,但也显著的肺积累.
- 优化脂质纳米粒子配方对于有针对性的交付和有效性至关重要.
研究的目的:
- 为了优化mRNA脂质复合物的PEGylation,以减少肺部积累.
- 评估优化脂质复合剂在抑制瘤生长中的有效性.
- 评估诱导的免疫反应,包括抗体和细胞毒性活性.
主要方法:
- 使用N-hexadecyl-N,N-dimethylhexadecan-1-aminium化物 (DC-1-16),DOPE和不同度的PEG-Chol,制备mRNA脂质复合物.
- 在具有EG7-OVA瘤的小鼠中静脉注射含有卵蛋白 (OVA) mRNA的优化脂质复合物 (LP-DC-1-16-3PCL).
- 对抗OVAIgG1水平的量化和对细胞毒性T淋巴细胞活性的评估.
- 与对照小鼠相比,对治疗小鼠的瘤生长抑制的监测.
主要成果:
- 用3mol%的PEG-Chol (LP-DC-1-16-3PCL) 进行PEGylation可以防止红细胞结合并减少肺积累.
- 静脉注射诱导了高水平的抗OVAIgG1 (83,000 mU/mL) 和强大的细胞毒性活性 (97%) 对EG7-OVA细胞.
- 与对照mRNA相比,LP-DC-1-16-3PCL脂质复合物显著抑制了EG7-OVA瘤的生长.
结论:
- 优化PEGylated mRNA脂质复合物 (LP-DC-1-16-3PCL) 有效地减少了肺部的积累.
- 这些脂质组诱导强大的幽默和细胞介导的抗瘤免疫反应.
- LP-DC-1-16-3PCL脂质复合体是通过静脉注射开发针对瘤的mRNA疫苗的有希望的策略.
相关概念视频
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...


